Indústria farmacêutica do Brasil e de Goiás durante as crises(2014-2021)

Abstract

This study analyzed the impacts of the 2014 crises and the pandemic on the Brazilian pharmaceutical industry and that of the state of Goiás, considering the period 2014-2021. The work was based on secondary data, mainly from the RAIS/MTE, PIA/IBGE, and Comex Stat databases, as well as reports from CMED and ANVISA, and academic articles and papers on the topic. Its main conclusions are that the pharmaceutical industry performed better than the overall manufacturing industry, which is related to the opportunities that the pandemic crisis opened up for the segment. At the same time, there was an increase in its external dependency and a deepening in its process of concentration. The pharmaceutical industry of Goiás stood out in this process, increasing its participation in the segment at the national level. It was also found that the process of concentration in the segment was more intense in the state, due to the process of consolidation of the pharmaceutical industry of Goiás, which had been underway since the early 2000s.